MiR-22 Plays A Key Role In Both Breast Cancer And Blood Cancer

[News]

A mere 25 years ago, noncoding RNAs were considered nothing more than "background noise" in the overall genomic landscape. Now, two new studies reveal that one of these tiny noncoding molecules - microRNA-22 - plays an outsized role in two types of cancer...

More... (http://www.medicalnewstoday.com/releases/262921.php)